Marek Kabat, Ph.D., D.Sc.

Marek Kabat, Ph.D., D.Sc. has extensive work experience in the pharmaceutical and biotechnology industries. Marek is currently serving as the Director of Process Chemistry at Navitor Pharmaceuticals since 2022. Prior to this, they worked as a CMC Consultant for Inmagene Biopharmaceuticals from 2020 to 2021, overseeing API development projects in China.

From 2017 to 2019, Marek worked at GSK as an Associate Director in the Platform Technology and Science Department. In this role, they provided technical leadership for metabolic markers and impurities projects and supported the outsourcing of complex chemistry projects.

Before joining GSK, Marek was an Executive Director at the Chemistry Manufacturing and Controls Department at Pharmaron in Beijing, China from 2014 to 2015. Marek was responsible for reviewing incoming projects, preparing price quotations, and managing multiple projects simultaneously.

Earlier in their career, Marek worked as a Senior Principal Scientist at Hoffmann-LaRoche Inc. in the Chemical Synthesis Department from 1993 to 2013. Marek was involved in developing synthetic processes, managing multi-step syntheses, and finding cost-effective routes for bulk drug substances.

Additionally, Marek has experience as a Senior Scientist at Hafslund-Nycomed in Oslo, Norway in 1992, where they worked on a peptide program. Marek also served as a Postdoc at the Sloan-Kettering Institute for Cancer Research in New York from 1985 to 1986, focusing on synthesizing nucleoside analogs.

Overall, Marek Kabat, Ph.D., D.Sc. has a strong background in process chemistry, CMC consulting, and technical leadership in the pharmaceutical industry, with a focus on API development and synthetic chemistry.

Marek Kabat, Ph.D., D.Sc. obtained a Ph.D. in Organic Chemistry from the Institute of Organic Chemistry, Polish Academy of Sciences in Warsaw, Poland. Prior to that, they completed their M.Sc. in Chemistry at the University of Warsaw. The specific years of their education are not provided.